Source:http://linkedlifedata.com/resource/pubmed/id/12119481
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-7-16
|
pubmed:abstractText |
The aim of the present study was to determine if treatment with an oral adsorbent (AST-120, Kremezin) might decrease the urinary albumin excretion and serum indoxyl sulfate (s-IS), and prevent glomerular sclerosis in early-stage renal failure, i.e. 0.9-1.2 mg/dl of serum creatinine (s-Cr) and 60-95 mg/dl of blood urea nitrogen (BUN), in subtotal (3/4) nephrectomized rats. Levels of s-Cr and s-IS in the AST-120-treated rats were significantly lower than those in the untreated control rats. The AST-120-treated rats showed an increase of creatinine clearance. Urinary protein and indoxyl sulfate excretion in the AST-120-treated rats were also significantly lower than those in the untreated control rats. The ratio of glomerular tuft area to the area of Bowman's capsules (GT/BC) in the AST-120-treated rats was significantly lower than that in the untreated control rats. The degree of glomerular sclerosis and tubulointerstitial fibrosis in the AST-120-treated rats was significantly lower than that in the untreated control rats. Furthermore, there was a significant relationship among the degree of GT/BC, glomerular sclerosis, tubulointerstitial fibrosis and the levels of urinary protein excretion. It appears that AST-120 might decrease the accumulation of s-Cr and s-IS, and prevent glomerular sclerosis in early stage renal failure in the subtotal nephrectomized rats.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0028-2766
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
480-5
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12119481-Adsorption,
pubmed-meshheading:12119481-Animals,
pubmed-meshheading:12119481-Blood Pressure,
pubmed-meshheading:12119481-Blood Urea Nitrogen,
pubmed-meshheading:12119481-Carbon,
pubmed-meshheading:12119481-Creatinine,
pubmed-meshheading:12119481-Fibrosis,
pubmed-meshheading:12119481-Indican,
pubmed-meshheading:12119481-Kidney,
pubmed-meshheading:12119481-Kidney Glomerulus,
pubmed-meshheading:12119481-Male,
pubmed-meshheading:12119481-Nephrectomy,
pubmed-meshheading:12119481-Oxides,
pubmed-meshheading:12119481-Rats,
pubmed-meshheading:12119481-Rats, Sprague-Dawley,
pubmed-meshheading:12119481-Renal Insufficiency,
pubmed-meshheading:12119481-Sclerosis
|
pubmed:year |
2002
|
pubmed:articleTitle |
Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats.
|
pubmed:affiliation |
Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
|
pubmed:publicationType |
Journal Article
|